Carbapenem resistant Gram-negative bacteremia in an Indian intensive care unit: A review of the clinical profile and treatment outcome of 50 patients

Indian Journal of Critical Care Medicine

Volumn 18, Issue 11, 2014, Pages 750-753

  Porwal, Ravikant ^a   Gopalakrishnan, Ram ^a   Rajesh, Naga Jawahar ^a   Ramasubramanian, V ^a  

^a APOLLO HOSPITALS   (India)

Author keywords

Bacteremia in Indian intensive care unit; carbapenem resistant Gram negative bacteremia; carbapenem resistant Klebsiella pneumoniae; multidrug resistant bacteremia

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; COLISTIN; CREATININE;

ABDOMINAL INFECTION; ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTERIAL GROWTH; BLOOD CULTURE; CARBAPENEM RESISTANT GRAM NEGATIVE BACTEREMIA; CATHETER INFECTION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMORBIDITY; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DISK DIFFUSION; ESCHERICHIA COLI; FEMALE; GLOMERULUS FILTRATION RATE; GRAM NEGATIVE SEPSIS; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INDIAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LOADING DRUG DOSE; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PSEUDOMONAS AERUGINOSA; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEPTIC SHOCK; SURVIVAL; SURVIVAL RATE; TERTIARY CARE CENTER; URINARY TRACT INFECTION; UROSEPSIS; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84911164378     PISSN: 09725229     EISSN: 1998359X     Source Type: Journal    
DOI: 10.4103/0972-5229.144021     Document Type: Article

References (10)

1. Untreatable: Report by CDC details today's drug-resistant health threats. Available from: http://www.cdc.gov/media/releases/2013/p0916-untreatable.html. [Last accessed on 2014 Mar 01]
2. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12
3. Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: Treatment options with carbapenems compromised. J Assoc Physicians India 2010;58:147-9
4. Nair PK, Vaz MS. Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai, India. J Microbiol Infect Dis 2013;3:207-10
5. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in North India. Indian J Med Res 2006;124:95-8
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement; M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute; 2011
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40
8. Shorr AF. Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med 2009;37:1463-9
9. Parthasarathy P. Risk factors and mortality in carbapenem resistant gram negative bacteremias: A retrospective analysis from a tertiary health care setting in India. Poster Abstract 1608, ID Week; 2013
10. Ghafur A, Kannaian P, Tayade A. Clinical study of carbapenum-sensitive and carbapenem-resistant bacteraemia in neutropenic and non-neutropenic patients: The first series from India. Abstract P 1368, 23rd ECCMID; 2013